7Baggers
 promising penny stocks to watch in october 2025  Yahoo Finance Wed, 01 Oct 2025 18:05:04 GMT
 published on: 2025-09-19 16:16:18  newser.com Fri, 19 Sep 2025 21:16:18 GMT
 relmada therapeutics regains nasdaq compliance  MSN Wed, 17 Sep 2025 22:09:25 GMT
 Relmada Therapeutics Updates Corporate Presentation on NDV-01  TipRanks Wed, 17 Sep 2025 07:00:00 GMT
 Relmada Regains Compliance with Nasdaq Minimum Bid Price Requirement  Investing News Network Tue, 16 Sep 2025 15:43:13 GMT
 Relmada regains Nasdaq compliance on minimum bid price  MSN Tue, 16 Sep 2025 14:28:07 GMT
 Relmada Therapeutics Regains Nasdaq Compliance  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 published on: 2025-09-15 17:44:42  newser.com Mon, 15 Sep 2025 22:44:42 GMT
 relmada regains nasdaq compliance on minimum bid price  MSN Mon, 15 Sep 2025 07:00:00 GMT
 published on: 2025-09-14 23:04:00  newser.com Mon, 15 Sep 2025 04:04:00 GMT
 published on: 2025-09-14 14:05:14  newser.com Sun, 14 Sep 2025 19:05:14 GMT
 published on: 2025-09-13 22:17:02  newser.com Sun, 14 Sep 2025 03:17:02 GMT
 published on: 2025-09-13 17:22:39  newser.com Sat, 13 Sep 2025 22:22:39 GMT
 published on: 2025-09-13 16:25:12  newser.com Sat, 13 Sep 2025 21:25:12 GMT
 relmada therapeutics cmo purchases 55,000 shares  MSN Fri, 12 Sep 2025 11:03:51 GMT
 relmada therapeutics issues mid-year ceo letter to shareholders  MarketScreener Thu, 11 Sep 2025 13:57:14 GMT
 relmada outlines phase 3 trial plans for bladder cancer drug ndv-01  StreetInsider Wed, 10 Sep 2025 11:16:51 GMT
 Relmada Issues Mid-Year CEO Letter to Shareholders  MarketScreener Wed, 10 Sep 2025 07:00:00 GMT
 relmada therapeutics cmo purchases 55,000 shares  MSN Sat, 06 Sep 2025 13:03:04 GMT
 relmada therapeutics cmo purchases 55,000 shares  MSN Fri, 05 Sep 2025 12:32:42 GMT
 published on: 2025-09-03 14:56:26  خودرو بانک Wed, 03 Sep 2025 11:27:39 GMT
 published on: 2025-09-03 04:51:26  Newser Wed, 03 Sep 2025 09:51:26 GMT
 Relmada Therapeutics executive purchases 55,000 shares on open market  Investing.com Tue, 02 Sep 2025 07:00:00 GMT
 Relmada Therapeutics CMO Purchases 55,000 Shares  TipRanks Tue, 02 Sep 2025 07:00:00 GMT
 Tuesday 9/2 Insider Buying Report: RLMD, STRA  Nasdaq Tue, 02 Sep 2025 07:00:00 GMT
 rlmd.o soars 44.5%—what’s behind the surge?  AInvest Mon, 01 Sep 2025 14:18:33 GMT
 3 Promising Penny Stocks With Market Caps Under $400M  simplywall.st Mon, 01 Sep 2025 07:00:00 GMT

Relmada Therapeutics, Inc
(NASDAQ:RLMD) 

RLMD stock logo

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, an oral agent, which is in Phase II clinical trial for the treatment of de...

Founded: 2004
Full Time Employees: 6
CEO: Sergio Traversa  
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends